Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Celltrion Healthcare New Zealand Limited, Clinician",Infliximab SC,All currently funded indications (adults >18years),Infliximab SC (REMSIMA SC),Only if cost neutral or cost saving,Community and Hospital,
